Medicare Enrolled
Dr. Abhishek Shah, M.D.
Cardiovascular Disease · Chula Vista, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Abhishek Shah is a cardiovascular disease specialist in Chula Vista, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 1,353 Medicare services across 936 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $37,165 from 37 pharmaceutical and/or device companies across 423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ 1,353 Medicare services
$37,165 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,353
Medicare services
Bottom 41% in CA for cardiovascular disease
936
Unique beneficiaries
$112
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~97 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
524 | $100 | $280 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
325 | $12 | $55 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
101 | $166 | $467 |
| Heart muscle strain imaging | 77 | $33 | $97 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
55 | $21 | $60 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
55 | $772 | $1,961 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $113 | $362 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
42 | $140 | $449 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $98 | $244 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
20 | $11 | $31 |
| Heart rhythm stimulator programming after drug infusion Adjustment of a heart rhythm stimulation device following a drug infusion. This procedure involves reprogramming the device settings to ensure proper function after the medication has been administered. |
18 | $70 | $270 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
18 | $10 | $113 |
| Heart chamber tissue destruction via catheter A procedure that destroys tissue in the upper heart chamber using a tube to treat abnormal heart rhythm. |
16 | $243 | $1,049 |
| Atrial fibrillation ablation with pulmonary vein isolation A procedure to treat atrial fibrillation by mapping the heart's electrical activity and destroying tissue causing irregular contractions. This is done by isolating the pulmonary veins using catheter-based destruction. |
15 | $752 | $1,871 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.1% high complexity
7.2% medium
81.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$37,165
Total received (2018-2024)
Avg $5,309/year across 7 years
Top 12% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
423
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,148 (59.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,750 (26.2%)
Scientific / Research
Research funding and grants
$5,195 (14.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$71 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$8,285
2023
$9,867
2022
$3,002
2021
$1,711
2020
$2,765
2019
$10,356
2018
$1,179
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medical Device Business Services, Inc.
$4,125
Abbott Laboratories
$1,993
HEARTFLOW, INC.
$613
Biosense Webster, Inc.
$346
Boston Scientific Corporation
$261
CARDIVA MEDICAL, INC.
$244
Edwards Lifesciences Corporation
$134
BIOTRONIK INC.
$101
Cleerly, Inc.
$83
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$73
Kestra Medical Technology Services, Inc.
$71
PFIZER INC.
$69
Kiniksa Pharmaceuticals International, plc
$42
Amgen Inc.
$29
E.R. Squibb & Sons, L.L.C.
$27
Novo Nordisk Inc
$24
AstraZeneca Pharmaceuticals LP
$21
Alnylam Pharmaceuticals Inc.
$16
CVRx, Inc.
$14
Top 3 companies account for 81.2% of 2024 payments
All-time payments by company (2018-2024) ›
Medical Device Business Services, Inc.
$9,750
Abbott Laboratories
$6,704
Boston Scientific Corporation
$6,507
Medtronic Vascular, Inc.
$6,124
BIOTRONIK INC.
$1,563
Biosense Webster, Inc.
$1,182
Edwards Lifesciences Corporation
$1,020
HEARTFLOW, INC.
$613
CARDIVA MEDICAL, INC.
$489
Shockwave Medical, Inc
$319
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$297
PFIZER INC.
$269
Impulse Dynamics (USA) Inc.
$251
Novartis Pharmaceuticals Corporation
$247
Medtronic, Inc.
$247
E.R. Squibb & Sons, L.L.C.
$230
Regeneron Healthcare Solutions, Inc.
$215
Janssen Pharmaceuticals, Inc
$169
BOSTON SCIENTIFIC CORPORATION
$148
ACIST MEDICAL SYSTEMS, INC.
$107
Cleerly, Inc.
$83
Alnylam Pharmaceuticals Inc.
$71
Kestra Medical Technology Services, Inc.
$71
ABIOMED
$67
Kiniksa Pharmaceuticals, Ltd.
$60
CVRx, Inc.
$45
CardioFocus, Inc.
$44
Kiniksa Pharmaceuticals International, plc
$42
Astellas Pharma US Inc
$40
AstraZeneca Pharmaceuticals LP
$34
Acutus Medical, Inc.
$30
Amgen Inc.
$29
Novo Nordisk Inc
$24
Daiichi Sankyo Inc.
$23
Esperion Therapeutics, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
iRhythm Technologies, Inc.
$15
Top 3 companies account for 61.8% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · AGILIS · AMVUTTRA · ASSURITY · AVEIR · Achieve · Acticor 7 VR-T DX · Arcalyst · Arctic Front · Asahi Fielder coronary guide wire · Assure WCD · Assurity Pacemaker · BIOMONITOR · Barostim Neo System · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CONFIRM RX · CVI SYSTEMS · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · Carto 3 · Carto 3 System · Carto CFAE · Carto Smarttouch · CartoSound · Cleerly Ischemia · Cobalt · Confidense · Confirm Rx · ELIQUIS · EMBLEM · ENSITE · ENSITE PRECISION · ENTRESTO · Edora · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · Ensite Cardiac Mapping System · FARXIGA · FFRct · Fortify Assura · GALLANT · GENERAL BRADY · GENERAL TACHY · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · General - Therapies · HEARTLIGHT SYSTEM · HeartMate 3 Left Ventricular Assist Device · IN.PACT Admiral · INJECTAFER · Impella · JARDIANCE · JOT DX · LATITUDE Communicator Power Supply · LEXISCAN · LINQ II · LOKELMA · Lexiscan · LifeVest · Micra · NEXLETOL · NUVISION ICE CATHETER · ONYX FRONTIER · Optimizer · Ozempic · PRALUENT ALIROCUMAB INJECTION · Passeo-18 · QDOT MICRO Catheter · QUADRA ASSURA · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE · RHYTHMVIEW · Repatha · RhythmVIEW Work Stations · Rivacor · S-ICD System Magnet · SAPIEN 3 Ultra RESILIA · SENSOR ENABLED · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Selectra · TACTICATH ABLATION CATHETER · TENDRIL · VersaCross Access Solution · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
198
Per 100K population
6.0
County median income
$102,285
Nearest hospital
SHARP CHULA VISTA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shah performed 524 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $37,165 from 37 companies across 423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other cardiologists in Chula Vista?
Dr. Shah's average Medicare payment per service is $112. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Chula Vista
Browse cardiologists in Chula Vista ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology